Vaccines R&D-2017 Featured Speakers
John Robert Coleman, Codagenix, Inc., USA
Hira L. Nakhasi, Food and Drug Administration (FDA), USA
Robert Hopkins, Emergent BioSolutions Inc, USA
Title: Development of Anthrax Vaccines for Post-Exposure Prophylaxis using FDA’s Animal Rule
Michael J Lacy, Emergent BioSolutions Inc, USA
Steven Singer, Georgetown University, USA
Title: Immune Responses to Giardia Infection
Shahin Gharakhanian, Cambridge Innovation Center, USA
Siba K. Samal, University of Maryland, USA
Armando Zuniga, Virometix AG, Switzerland
Rocky Cranenburgh, Prokarium, UK
Title: Development of an oral, thermo-stable vaccine for plague using the Vaxonella platform
Michael Hust, Technische Universität Braunschweig, Germany
Alessandro Sette, La Jolla Institute for Allergy and Immunology, USA
Farshad Guirakhoo, GeoVax, Inc., USA
Giulio Philip Tarro, Fondazione de Beaumont Bonelli per le ricerche sul cancro, Italy
Filip Dubovsky, MedImmune USA
Nora Dellepiane, Serum Institute of India, Switzerland
Title: Challenges for vaccine regulation
Stephen Albert Johnston, The Biodesign Institute ASU, USA
Ann M. Ginsberg, AERAS, USA
Samuel Bogoch, Replikins, Ltd., USA
Vidadi Yusibov, University of Delaware, USA
Marjorie Robert-Guroff, National Cancer Institute, USA
Barbara K. Felber, National Cancer Institute, USA
Ravi A. Madan, National Cancer Institute, USA
Kwong Y Tsang, National Cancer Institute, USA
Title: Studies of a novel combination of recombinant adenovirus vaccines containing CEA, MUC1 or Brachyura epitopes as an immunotherapyeutic
Duccio Medini, GSK, Italy
Title: Data Science for Vaccines R&D: the meningococcal vaccine Bexsero from discovery to implementation
Yvonne Saenger, New York Presbyterian Hospital, USA
Title: Immune Biomarker in Early Stage Melanoma
James E. Galen, University of Maryland School of Medicine, USA
Laurent M. Humeau, Inovio Pharmaceuticals, USA
Title: Advances in DNA Vaccine Developments
Tong-Ming Fu, Merck, USA
Osama Rahma, Dana-Farber Cancer Institute, USA
Title: Cancer vaccine development
Sophie Barreteau, VitamFero SA, French
Gustavo Moreira, Technische Universität Braunschweig, Germany
George N. Pavlakis, National Cancer Institute, USA
Christopher Heery, National Cancer Institute, USA
Edmund J. Gosselin, Albany Medical College, USA
Title: Adjuvant-Independent Intranasal Vaccination Via Human FcgmmaRI-Targeted Fusion Protein
Kristina De Paris, UNC at Chapel Hill, USA
Title: The road to a pediatric HIV vaccine
Ali I. Fattom, NanoBio, USA
Hong Shen, Elsa Biologics, USA
Shiladitya DasSarma, University of Maryland School of Medicine, USA
Title: Antigen display and therapeutic potential of a buoyant VLP-like nanoparticle
Fusataka Koide, Southern Research, USA
Title: Emerging and Re-emerging Mosquito-Borne Infectious Diseases – The Role of Non-human Primate Models in Vaccine Development
James L. Gulley, National Cancer Institute, USA
Gunnveig Grødeland, University of Oslo and Oslo University Hospital, Norway
Title: APC-targeting of antigen for increased efficacy of vaccination
James Moon, University of University of Michigan, USA
Title: Nanodisc platform for personalized neo-antigen vaccination
Mario Skiadopoulos, Emergent Biosolutions, USA
Title: Comparative Analysis of the Antibody Threshold of Protection for the Licensed Biothrax Anthrax Vaccine and Other Novel Anthrax Vaccine Candidates
Joost J. Oppenheim, National Cancer Institute, USA
Title: TLR ligands as anti tumor vaccines in mice
Malabi M Venkatesan, Walter Reed Army Institute of Research (WRAIR), USA
Title: WRAIR's Shigella vaccine development
Ahmed Bouzidi, Vaxeal Group, Switzerland
Title: Pre-Clinical Development Of SVX-1 : A Novel Therapeutic Cancer Vaccine
Jean Marie Andrieu, Descartes University, Paris
Barbara Ensoli, Istituto Superiore di Sanità, Italy
Ruth Ruprecht, Texas Biomedical Research Institute, USA
Jay Bream, Johns Hopkins University, USA
Cyril Gerard Gay, USDA/ARS, USA
Title: Veterinary vaccine research in support of biodefense and the threat of biological threat agents
Mei Cong, Promega Corp, USA
Klaus Überla, University Hospital Erlangen, Virology Institute, USA
Moriya Tsuji, Aaron Diamond AIDS Research Center, Rockefeller Univ, USA
Spyros Kalams, Vanderbilt University Medical Center, USA
Teri Heiland, Immunomic Therapeutics, USA
Ursula Buchholz, RNA Viruses Section NIAID, NIH USA
Title: Pediatric live-attenuated RSV vaccine candidates
Nicolas Çuburu, National Cancer Institute, USA
Title: New Viral Vector for Therapeutic Vaccination Against HPV-associated Neoplasia
Jasmin Leshem, National Cancer Institute, USA
Title: Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Eradicates Murine Cancer by Promoting Anti-Cancer Immunity
Mahin Khatami, National Cancer Institute (retired), USA
Title: Scientific Analyses of Data on Specific Vaccines and Immunity
Wendy Watford, University of Georgia, USA
Title: Induction of IFN-lambda production and anti-viral activity by the serine-threonine kinase, Tpl2: implications for influenza vaccine development
Ewan Plant, US Food & Drug Administration, USA
Title: How the annual influenza vaccination affects the antibody response to drifted viruses
Leonardo Marino-Ramirez, NIH/NLM/NCBI, USA
Title: Developing Vaccines in the Genomics Era
Andrea Facciabene, University of Pennsylvania, USA
Title: PD-1/PD-L1 antagonism increase efficacy of mitochondria based vaccine
Teresa de los Santos, ARS, USDA, USA
Title: FMD vaccines in the veterinary vaccine section
Amy Rosenberg, US Food & Drug Administration, USA
Title: Rescue of T cell Mediated Vaccine Immunity following Sublethal Irradiation
Scot Roberts, Altimmune, Inc., USA
Jerald Sadoff, Janssen Vaccines & Prevention B.V., The Netherlands
Konstantin Virnik, FDA/CBER, USA
Mariola Fotin-Mleczek, CureVac AG, Germany
Michael A. Egan, Profectus Biosciences, Inc., USA
Title: Development of the VesiculoVax™-vectored Vaccine Platform to Rapidly Respond to New Epidemic Diseases
Ashley Birkett, PATH Malaria Vaccine Initiative (MVI), USA
Elisa Scarselli,Nouscom Srl, Italy
Purnima Dubey, Wake Forest University Health Sciences, USA
Title: Reshaping acellular pertussis vaccine-induced immune responses by the novel adjuvant, BcfA
Paul Keller, FDA - CBER, USA
Andrea L. Cox, Johns Hopkins University, USA
Title: How close are we to realizing a hepatitis C vaccine- and do we need one?
Adan Rios, University of Texas Medical School in Houston, USA
Richard Wyatt, Scripps Institute in La Jolla, CA, USA
Graham Pawelec, University of Tuebingen, Germany
Title: Immune frailty: role of viral infection and impact on vaccination in the elderly
Yongjun Sui, National Cancer Institute, USA
Title: Orally delivered mucosal vaccine targeting colorectal immunity protected SHIV transmission in macaques
Klaus Schwamborn, Valneva, France
Title: Responding to the threat of emergent infectious diseases
Yoshikazu Kurosawa, Fujita Health University, Japan
Title: Analysis of antibody repertoires induced by vaccination with four kinds of H5N1 viruses in twenty volunteers
Laura Hong, Merck, USA
Title: Pivotol role of cellular necrosis in residual cytotoxicity of a recombinant vaccine against Clostridium Difficile
Danushka Kumara Wijesundara, The University of Adelaide, Australia
Title: Cytolytic DNA vaccine to induce antigen cross-presentation by dendritic cells and liver tissue resident memory CD8+ T cells
Adan Rios, The George McGovern Medical School at Houston Texas, USA
Title: Fundamental challenges to the development of an HIV vaccine
Mark C. Poznansky, Harvard Medical School, USA
Title: Accelerated development of a T cell based vaccine for Q Fever